Recertify to Continue Dispensing Clozapine

Please see the FDA notice concerning Clozapine REMS program updates/deadline extensions.

A SINGLE new registry will streamline clozapine use and dispensing.

Clozapine is very effective for schizophrenia. But it's often considered a last resort due to neutropenia and other side effects.

The new Clozapine REMS Program is now the ONLY registry available.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote